Review article: vitamin D and inflammatory bowel diseases.

Review article: vitamin D and inflammatory bowel diseases.
复制标题

DOI:
10.1111/apt.12553
复制
发表时间:
2014-01
影响因子:
7.6
通讯作者:
Ananthakrishnan AN
Ananthakrishnan AN
中科院分区:
医学1区
文献类型:
--
作者:
Mouli VP;Ananthakrishnan AN

文献摘要

参考文献

被引文献

相似文献

维生素D与骨代谢有关。维生素D的免疫作用越来越受到关注。回顾支持维生素D在炎症性肠病中作用的证据。使用术语“克罗恩病”、“溃疡性结肠炎”和“维生素D”在PubMed上进行了全面检索。维生素D缺乏在IBD患者(16-95%)中很常见,包括最近诊断出疾病的患者。证据支持维生素D在IBD中的免疫作用。在动物模型中,缺乏维生素D会增加对DSS结肠炎的易感性,而1,25(OH)2D 3会改善这种结肠炎。一项前瞻性队列研究发现,低预测维生素D水平与CD风险增加相关。有限的数据还表明,低维生素D水平和疾病活动增加之间存在关联,特别是在克罗恩病中。在一个大型队列中,维生素D缺乏(<20 ng/mL)与CD患者手术风险(OR 1.8,95% CI 1.2 - 2.5)以及CD(OR 2.1,95% CI 1.6 - 2.7)和UC(OR 2.3,95% CI 1.7 - 3.1)患者住院风险增加相关。一项随机对照试验表明,与安慰剂相比,补充维生素D可能与克罗恩病患者复发频率降低有关(13% vs. 29%,p = 0.06)。越来越多的流行病学证据表明,维生素D缺乏在IBD的发展中起作用,并影响疾病的严重程度。维生素D在IBD患者中可能的治疗作用值得继续研究。
Vitamin D is traditionally associated with bone metabolism. The immunologic effects of vitamin D have increasingly come into focus. To review the evidence supporting a role of vitamin D in inflammatory bowel diseases. A comprehensive search was performed on PubMed using the terms “crohn’s disease” “ulcerative colitis” and “vitamin D” Vitamin D deficiency is common in patients with IBD (16–95%) including those with recently diagnosed disease. Evidence supports immunologic role of vitamin D in IBD. In animal models, deficiency of vitamin D increases susceptibility to DSS colitis while 1,25(OH)2D3 ameliorates such colitis. One prospective cohort study found low predicted vitamin D levels to be associated with an increased risk of CD. Limited data also suggests an association between low vitamin D levels and increased disease activity, particularly in Crohn’s disease. In a large cohort, vitamin D deficiency (< 20ng/mL) was associated with increased risk of surgery (OR 1.8, 95% CI 1.2 – 2.5) in CD and hospitalizations in both CD (OR 2.1, 95% CI 1.6 – 2.7) and UC (OR 2.3, 95% CI 1.7 – 3.1). A single randomized controlled trial demonstrated that vitamin D supplementation may be associated with reduced frequency of relapses in patients with Crohn’s disease compared to placebo (13% vs. 29%, p = 0.06). There is growing epidemiological evidence to suggest a role for vitamin D deficiency in the development of IBD and also its influence on disease severity. The possible therapeutic role of vitamin D in patients with IBD merits continued investigation.
DOI: 10.7205/milmed-d-10-00371
发表时间: 2011-06-01
期刊: MILITARY MEDICINE
影响因子: 1.2
作者:
Atia, Antwan;Murthy, Ravindra;Peiris, Alan N.
通讯作者: Peiris, Alan N.
DOI: 10.3945/ajcn.112.034967
发表时间: 2012-08-01
影响因子: 7.1
作者:
Ganmaa, Davaasambuu;Giovannucci, Edward;Willett, Walter C.
通讯作者: Willett, Walter C.
DOI: 10.1093/ajcn/80.6.1717s
发表时间: 2004-12-01
影响因子: 7.1
作者:
Cantorna, MT;Zhu, Y;Wittke, A
通讯作者: Wittke, A
DOI: 10.1097/mpg.0b013e31826a105d
发表时间: 2013-01-01
影响因子: 2.9
作者:
Alkhouri, Razan H.;Hashmi, Humaira;Baker, Susan S.
通讯作者: Baker, Susan S.
维生素 D 介导的单核细胞抗菌反应的变阻调节。
DOI: 10.4049/jimmunol.0803736
发表时间: 2009-04-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Adams JS;Ren S;Liu PT;Chun RF;Lagishetty V;Gombart AF;Borregaard N;Modlin RL;Hewison M
通讯作者: Hewison M